About
What it is and where it shows up.
Amla extract is derived from the fruit of Phyllanthus emblica L. (Indian gooseberry), a tree native to India and Southeast Asia, and is exceptionally rich in polyphenols, tannins, and vitamin C. It is widely used as a natural antioxidant, anti-inflammatory, and nutraceutical ingredient in functional foods, dietary supplements, and traditional medicine.
Safety summary
The regulatory and scientific consensus.
Clinical studies show amla extract is well-tolerated at typical supplemental doses, with no significant adverse effects on liver or renal function observed in human trials. Its very high vitamin C content (reported at 1,100–1,700 mg/100 g of fresh fruit) may cause gastrointestinal discomfort at high doses, and in vitro anticoagulant properties suggest caution for individuals on blood-thinning medications. No formal Acceptable Daily Intake (ADI) has been established by any major regulatory body, as amla is treated as a botanical food/traditional ingredient rather than a conventional food additive.
Regulatory landscape
What food-safety regulators have decided.
| Jurisdiction | Status | Note |
|---|---|---|
| EFSA (European Food Safety Authority) (European Union) | Approved | Amla (Emblica officinalis / Phyllanthus emblica) is permitted as a botanical food ingredient and dietary supplement in the EU. EFSA's 2011 Scientific Opinion (NDA Panel) assessed health claims for LDL-cholesterol maintenance (ID 4041) and oxidative damage protection (ID 4042) but did not substantiate these specific claims due to insufficient evidence under Regulation (EC) No 1924/2006. No E-number is assigned; it is not regulated as a conventional food additive.source |
| FSSAI (Food Safety and Standards Authority of India) (India) | Approved | Amla (fruit, juice, or minimally processed form) is explicitly recognised as a traditional food ingredient under FSSR and does not require nutraceutical classification in that form. When formulated as a concentrated extract in health supplements or nutraceuticals, compliance with FSS (Health Supplements, Nutraceuticals, FSDU, FSMP, Functional Food and Novel Food) Regulations, 2016 is required. Specific health benefit claims require prior approval from the Food Authority. Water, ethyl alcohol, or hydro-alcoholic extraction processes are permitted for botanical extracts under these regulations.source |
| FDA (Food and Drug Administration) (United States) | Approved | Amla extract does not appear as a named substance in the FDA Food Additive Status List and is not assigned an explicit GRAS status in 21 CFR Parts 182 or 184. It is marketed and consumed in the US primarily as a dietary supplement ingredient under DSHEA (1994), where manufacturers bear responsibility for establishing and maintaining safety prior to marketing.source |
Who should approach with care
Whose guidance would steer them away.
Pregnancy — No controlled safety data exist for high-dose concentrated amla extract during pregnancy; traditional use is as a whole fruit or food, and supplemental extract doses have not been clinically evaluated in pregnant populations.
Lactation — Insufficient clinical trial data are available on concentrated amla extract supplementation during breastfeeding; whole-food consumption is generally considered safe, but extract-level dosing is unstudied in this population.
Kidney Disease — Amla fruit contains oxalic acid and very high vitamin C levels; at supplemental extract doses, increased urinary oxalate excretion may worsen kidney stone risk in individuals with existing nephrolithiasis or reduced renal clearance.
Diabetes — Amla extract exhibits documented antidiabetic activity that may potentiate the blood glucose-lowering effect of antidiabetic medications, warranting blood glucose monitoring and possible dose adjustment.
Heart Disease — In vitro studies have demonstrated anticoagulant activity (serine protease inhibition and extended prothrombin time) for amla methanolic extract; individuals on anticoagulant or antiplatelet therapy should seek medical advice before using concentrated amla supplements.
Research citations
The sources behind this verdict.
- 1PubMed. Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients. pubmed.ncbi.nlm.nih.gov
- 2PubMed. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial. pubmed.ncbi.nlm.nih.gov
- 3PubMed. Functional and Nutraceutical Significance of Amla (Phyllanthus emblica L.): A Review, 2022. pmc.ncbi.nlm.nih.gov
- 4FSSAI. FAQs on Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2020. fssai.gov.in
- 5EFSA. Scientific Opinion on the substantiation of health claims related to the raw fruit of Emblica officinalis Gaertn. and maintenance of normal blood LDL-cholesterol concentrations (ID 4041) and protection of DNA, proteins and lipids from oxidative damage (ID 4042) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, 2011. efsa.europa.eu
Independently researched5 citations